Logo Navarrabiomed

ENES  Vimeo
Inicio / News / Biomedical Research Network Refbio Ii Finances Four Projects Hospital Complex Navarre and

The biomedical research network Refbio II finances four projects of the Hospital Complex of Navarre and Navarrabiomed

31/05/2017
Autor: 
Navarrabiomed
Researchers: Marisa Gomez, Maite Mendioroz, Julián Libreo and Imanol Arozarena.

Refbio II, the second phase of the Pyrenean Biomedical Trans border Research Network, supports seven research projects in total, four of which have the participation of Navarrese researchers from the Hospital Complex of Navarra (CHN) and Navarrabiomed. The projects were selected from 15 proposals submitted to the internal call of the Network whose total funding exceeds 400,000 euros.

The four projects that take place in Navarre started on May 1st, and together they have a financing of 256,840 euros, of which 91,840 euros are directed to actions carried out directly at the CHN and Navarrabiomed.

Each Project involves between 3 and 5 partners, always guaranteeing a research group on each side of the Pyrenean slope. In total, 16 research groups belonging to biomedical research centers, hospital institutions, universities or companies will cooperate during the 18 months of development of each project.

Selected Projects

Of the four projects selected, one of them is led by Dr. Marisa Gómez, a pathologist at the Pathological Anatomy Service of the Hospital Complex of Navarra. The study addresses the search for biomarkers in colorectal cancer and its team will work in coordination with two other partners of the Network: the Biomedical Research Center of La Rioja and the University Hospital of Toulouse.

In the other three funded initiatives, Navarrabiomed participates as a partner through its researchers Drs. Imanol Arozarena, Julián Librero and Maite Mendioroz, the latter also a neurologist from the CHN. Their projects are focused on the search and validation of biomarkers in melanoma, analysis of mechanisms of neurodegeneration and new drugs for the treatment of type 2 diabetes.

More On Refbio

The second phase of Refbio (2016-2018) is defined as the stage in which the biomedical cross-border research network will further develop the effective transfer of biomedical R & D results and their development in the Pyrenees area.

The project is co-financed 65% by the European Regional Development Fund (ERDF) under the Interreg V-A Spain-France-Andorra Program (POCTEFA 2014-2020). The objective of POCTEFA is to strengthen the economic and social integration of the Spain-France-Andorra border area. Its assistance focuses on the development of cross-border economic, social and environmental activities through joint strategies for sustainable territorial development.

Refbio II is composed of the following partners:

  • Navarrabiomed-Fundación Miguel Servet – Project Leader. 
  • Asociación Instituto Biodonostia (BIODONOSTIA).
  • Asociación Instituto de Investigación Sanitaria Biocruces (BIOCRUCES).
  • Centre Hospitalier Universitaire de Toulouse (CHU Toulouse).
  • Centro de Investigación Biomédica de La Rioja (CIBIR).
  • Cluster Santé Osasuna de Aquitania.
  • Fundación Vasca de Innovación e Investigación Sanitarias (BIOEF).
  • Instituto Aragonés de Ciencias de la Salud. (IACS)
  • Université Paul Sabatier de Toulouse (UPS).

 

X
Enter your NAVARRABIOMED: Plataforma científica al servicio de los profesionales sanitarios username.
Enter the password that accompanies your username.
Loading